🇺🇸 Naloxone Nasal Spray in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arthralgia — 2 reports (15.38%)
  2. Dyspnoea — 2 reports (15.38%)
  3. Pneumonia — 2 reports (15.38%)
  4. Abdominal Distension — 1 report (7.69%)
  5. Back Pain — 1 report (7.69%)
  6. Catheter Site Haemorrhage — 1 report (7.69%)
  7. Chronic Obstructive Pulmonary Disease — 1 report (7.69%)
  8. Condition Aggravated — 1 report (7.69%)
  9. Cough — 1 report (7.69%)
  10. Cyanosis — 1 report (7.69%)

Source database →

Other Emergency Medicine / Toxicology approved in United States

Frequently asked questions

Is Naloxone Nasal Spray approved in United States?

Naloxone Nasal Spray does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Naloxone Nasal Spray in United States?

Pocket Naloxone Corp is the originator. The local marketing authorisation holder may differ — check the official source linked above.